IQGLF yields 33.33% · PFE yields 6.13%● Live data
📍 IQGLF pulled ahead of the other in Year 1
Combined, IQGLF + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of IQGLF + PFE for your $10,000?
IQGeo Group plc develops geospatial software to the telecoms and utility network industries in the United Kingdom, Europe, the United States, Canada, Japan, and internationally. The company provides IQGeo Platform, which designs and manages complex and constantly evolving network assets; IQGeo Network Manager that plans, designs, and supports network lifecycle through construction and maintenance operations; IQGeo Workflow Manager software, which helps to control telecom and utility construction and maintenance activities; IQGeo Inspection and Survey software that provides a flexible mobile interface for field inspection teams; and IQGeo Network Revenue Optimizer software, which automatically produces multiple telecom construction route options for connecting commercial or residential premises. It also offers IQGeo development environment to implement applications that work in any modern web browser and on any mobile device, online or offline; IQGeo Fiber Planning software, which automatically generates a cost-optimized next-generation fiber network plan and design; IQGeo in the cloud, a cloud hosting of critical system infrastructure; IQGeo GIS integrations for data integration from virtually any application and geospatial data source; and IQGeo professional services. The company was formerly known as Ubisense Group Plc and changed its name to IQGeo Group plc in January 2019. IQGeo Group plc was founded in 2002 and is headquartered in Cambridge, the United Kingdom.
Full IQGLF Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.